Zorro, an Israeli insurtech startup that has developed a platform to optimize the health benefits experience for employees, employers, and brokers, raised $11.5 million in a Seed funding round co-led by Pitango and 10D.
This is the second time so far in March that an Israeli startup in the field of insurtech has raised funds. Fairmatic, an Israeli startup specializing in Insurtech 2.0, announced in March that it had raised $46 million in new funding just six months after its oversubscribed Series A brought in $42 million.
Zorro was founded by Guy Ezekiel and Maya Perl who met as two HealthTech investors at Pitango, one of Israel’s largest VC funds. The two say they are on a mission to revolutionize the way Americans plan for, pay for, save for, and think about healthcare insurance and services.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Over half of the American adults report struggling with healthcare costs, but no financial support system exists to help them, explains Zorro. The company said that its first step is to create a better model for employer-sponsored health benefits. Zoro’s long-term vision is to be the healthcare financial companion of the future.
“Zorro sits at the exciting intersection of the healthcare and financial sectors, and we’re proud to have developed a technology that makes offering employee health insurance plans more transparent, cost-effective and personalized,” said Guy Ezekiel, CEO and co-founder of Zorro.
In explaining why he founded Zoro, Ezekiel said, “For me this was part of a lifelong entrepreneurial journey that always had me looking for the next mountain to climb. I am fortunate to have led multiple innovative healthcare companies that made a huge positive impact. But until Zorro, my companies built niche products that touched a select number of patients. I wanted to build something that could touch anyone who needs health services and that is a game-changing, category-defining product.”